medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2020, Número 629

<< Anterior Siguiente >>

Rev Med Cos Cen 2020; 86 (629)


Infección por COVID-19 en población adulta mayor: recomendaciones para profesionales

Leandro-Astorga G, Barrientos CI

Idioma: Español
Referencias bibliográficas: 34
Paginas: 44-50
Archivo PDF: 181.28 Kb.


RESUMEN

El 11 de marzo 2020 la Organización Mundial de la Salud decretó estado de pandemia por el SARS-CoV-2, desde ahí las publicaciones científicas han señalado a la población adulta mayor como una de poblaciones más vulnerables y con la mayor tasa de mortalidad. Se han identificado algunos factores de riesgo como los cambios fisiológicos del envejecimiento, la disminución de la función inmune y sobre todo la comorbilidad, principalmente la hipertensión arterial y las enfermedades cardiovasculares. Lo anterior relacionado con el uso de fármacos como los inhibidores de la enzima convertidora de angiotensina II, los cuales regulan el receptor ACE-2, el mismo receptor que el virus SARS-CoV-2 utiliza para entrar en las células huésped. Las decisiones terapéuticas en las personas mayores pueden ser difíciles en determinadas circunstancias, es ahí donde los geriatras deben actuar para la toma de decisiones basadas en las condiciones clínicas y funcionales y no solo en función de la edad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Zhou F, Yu T, Du R, Fan G, Liu Y, Xiang J et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet.2020;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.

  2. Ministerio de Salud, Costa Rica, 2020. Situación Nacional Covid19, 22 abril 2020

  3. Huang Ch, Wang Y, Li X, Ren L, Zhao J, Hu Y, y cols. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497– 506

  4. Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. Published online April 06, 2020. doi:10.1001/jama.2020.5394

  5. Liu K, Chen Y, Lin R y Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-agedpatients. J Infect. 2020; S0163-4453(20)30116-X. doi: 10.1016/j.jinf.2020.03.005.

  6. Landi F, Barillaro C, Bellieni A, et al. The New Challenge of Geriatrics: Saving Frail Older People from the SARS-CoV-2 Pandemic Infection [published online ahead of print, 2020 Apr 3]. J Nutr Health Aging. 2020;1–5. doi:10.1007/s12603-020-1356-x

  7. Aprahamian I, Cesari M. Geriatric Syndromes and SARS-CoV-2: more than just being old. J Frailty Aging. Published online April 14, 2020, http://dx.doi.org/10.14283/jfa.2020.17

  8. Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R, Aggarwal CS, Vunnam RR, Sahu N, Bhatt D, Jones K, Golamari R, Jain R. COVID-19 and Older Adults; What We Know.J Am Geriatr Soc. 2020 Apr 7. doi: 10.1111/jgs.16472.

  9. Esme M, Topeli A, Yavuz BB, Akova M. Infections in the Elderly Critically-Ill Patients.Front Med (Lausanne). 2019 Jun 6;6:118. doi: 10.3389/fmed.2019.00118.

  10. Pawelec G. Age and immunity: What is immunosenescence"? Exp. Gerontol. 2018; 105:4-9.

  11. Fülöp T, Dupuis G, Witkowski JM y Larbi A. The Role of Immunosenescence in the Development of Age- Related Diseases. Rev Invest Clin. 2016; 68(2):84-91.

  12. Ministerio de Salud, Costa Rica. 2018. Memoria Institucional

  13. Vaduganathan M, Vardeney O, Michel T, McMurray JJV, Pfeffer MA y Solomon SD. Renin-Angiotensin- Aldosterone System Inhibitors in Patients with Covid-19. N Engl Med. 2020; Mar 30. doi: 10.1056/NEJMsr2005760. [Epub ahead of print]

  14. Chung HY, Kim DH, Lee EU, Chung LW, Chung S, Lee B et al. Redefining Chronic Inflammation in Aging and Age-Related Diseases: Proposal of the Senoinflammation Concept. Aging Dis. 2019;10(2):367- 382

  15. Morley JE, Vellas B. COVID-19 and Older Adults. J Nutr Health Aging. 2020;24(4):364-365. doi: 10.1007/s12603- 020-1349-9.

  16. Malone M et al. COVID-19 in Older adults: Key points for Emergency Department Providers. Journal of Geriatric Emergency Medicine. March 18, 2020 Vol 1 Issue 4

  17. Boreskie KF, Boreskie PE y Melady D. Age is just a number - and so is frailty: Strategies to inform resource allocation during the COVID-19 pandemic. CJEM. 2020; 1:1-5. doi: 10.1017/cem.2020.358.

  18. Handforth C, Clegg A, Young C, Simpkins S, Seymour MT, Selby PJ, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol 2015;26(6):1091-101)

  19. Fried P, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: Evidence for a phenotype. J Gerontol Med Sci.2001;56A:146–56.3

  20. Guan C y Niu H. Frailty assessment in older adults with chronic obstructive respiratory diseases. Clin Interv Aging. 2018; (29)13:1513-1524

  21. Abbasi M, Rolfson D, Khera A, Dabravolskaj J, Dent E y Xia L. Identification and management of frailty in the primary care setting. CMAJ 2018;24(190):1134-1140

  22. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005 Aug 30;173(5):489–95.

  23. Overview | COVID-19 rapid guideline: critical care | Guidance | NICE [Internet]. NICE; [cited 2020 Mar 24]. Available from: https://www.nice.org.uk/guidance/ng159

  24. Marcantonio ER. Delirium in Hospitalized Older Adultos. N Engl J Med. 2017;377(15):1456-1466. doi: 10.1056/NEJMcp1605501

  25. Star A, Boland JW. Updates in palliative care-recent advancements in the pharmacological management of symptoms. Clin Med (Lond). 2018 Feb;18(1):11-16. doi: 10.7861/clinmedicine.18-1-11.

  26. Gaertner J, Eychmueller S, Leyhe T, Bueche D, Savaskan E, Schlögl M. Benzodiacepines and/or neuroleptics for the treatment of delirium in palliative care? A critical appraisal of recent randomized controlled trials. Ann Palliat Med. 2019 Sep;8(4):504- 515. doi: 10.21037/apm.2019.03.06

  27. Scottish Intercollegiate Guidelines Network (SIGN). Risk reduction and management of delirium. Edinburgh: SIGN;2019. Available from URL: http://www.sign.ac.uk

  28. British Geriatrics Society, European Delirium Association, Old Age Psychiatry Faculty. Coronavirus: Managing delirium in confirmed and suspected cases. [Internet]. . London: British Geriatrics Society; [update 2020 March 25] Available www.bgs.org.uk/COVID.19

  29. Sociedad Española de Geriatría y Gerontología. Manejo farmacológico de trastornos psicóticos en personas mayores con tratamiento de la infección por COVID19: interacciones y recomendaciones terapéuticas. 2020.

  30. Tark A, Estrada LV, Tresgallo ME, Quigley DD, Stone PW, Agarwal M. Palliative care and infection management at end of life in nursing homes: A descriptive survey. Palliat Med. 2020 Mar 10:269216320902672. doi: 10.1177/0269216320902672.

  31. Hardinge M , Annandale J , Bourne S et al . British Thoracic Society guidelines for home oxygen use in adults . Thorax 2015 ; 70 ( Suppl 1 ): i1 – 43

  32. Ekstrom MP , Abernethy AP , Currow DC . The management of chronic breathlessness in patients with advanced and terminal illness . BMJ 2015 ; 349 : g7617

  33. NHS. Clinical guide for the management of palliative care in secondary care during the coronavirus pandemic, Version 1. 2020. Available from https://www.england.nhs.uk/coronavirus/

  34. Gijzel S, Whitson H, Van de Leemput I, Scheffer M, Van Asselt D, Rector J, Rikkert M y Melis R. Resilience in Clinical Care: Getting a Grip on the Recovery Potential of Older Adults. JAGS 00:1-8, 2019.




2020     |     www.medigraphic.com